Based on the aap Implantate AG stock forecast from 0 analysts, the average analyst target price for aap Implantate AG is not available over the next 12 months. aap Implantate AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of aap Implantate AG is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, aap Implantate AG’s stock price was EUR 0.92. aap Implantate AG’s stock price has changed by +21.05% over the past week, +21.85% over the past month and -39.87% over the last year.
No recent analyst target price found for aap Implantate AG
No recent average analyst rating found for aap Implantate AG
Company Overview aap Implantate AG
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, and shoulder; and a range of cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany, and through a network of distributors internationally. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany. Address: Lorenzweg 5, Berlin, Germany, 12099 Read Less
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, and shoulder; and a range of cannulated screws. The company sells its products directly to hos...Read More
Frequently Asked Questions About aap Implantate AG (AAQ1:XETRA) Stock
Stock Target Advisor's fundamental analysis for aap Implantate AG's stock is Bearish.
Unfortunately we do not have enough data on AAQ1:XETRA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AAQ1:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AAQ1:XETRA's stock to indicate if its overvalued.
The last closing price of AAQ1:XETRA's stock was EUR 0.92.
The most recent market capitalization for AAQ1:XETRA is EUR 9.07M.
Unfortunately we do not have enough analyst data on AAQ1:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains aap Implantate AG's stock.
As per our most recent records aap Implantate AG has 111 Employees.
aap Implantate AG's registered address is Lorenzweg 5, Berlin, Germany, 12099.
You can get more information about it from aap Implantate AG's website at https://www.aap.de.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AAQ1:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
